×

Equipment and Services Health Care Equipment and Supplies

  • Cramer Remix: Why these US oil fields may be about to make a big market impact

    Jim Cramer has his eyes on an energy asset sale that could make major waves on Wall Street.

  • Jim Cramer on "Mad Money"

    Jim Cramer has his eyes on an energy asset sale that could make major waves on Wall Street.

  • Cardinal Health CEO: How my pharma giant is bucking a difficult environment

    Jim Cramer sat down with George Barrett, the chairman and CEO of Cardinal Health, to see how his health care giant is faring.

  • *1st- qtr rev $7.39 bln vs est $7.45 bln. Shares of the Dublin- based company, which makes heart devices, spinal implants and insulin pumps, dipped as much as 3 percent to $81.00 in morning trading. Sales in Medtronic's diabetes business, which includes artificial pancreas devices and insulin pumps, fell about 1 percent to $449 million in the first quarter ended July...

  • Net income attributable to Medtronic rose to $1.02 billion, or 74 cents per share in the first quarter ended July 28, from $929 million, or 66 cents per share, a year earlier. Net sales climbed 3.1 percent to $7.39 billion. Dublin- based Medtronic generates most of its sales from heart devices, spinal implants and insulin pumps.

  • LONDON, Aug 21- Britain's Creo Medical Group said its device to remove cancerous lesions in the bowel during an endoscopy had received U.S. approval much quicker than it planned, shaking up a timetable that had been focused on a European launch. The company, which listed late last year, said the U.S. Food and Drug Administration had cleared its Speedboat RS2 device...

  • NEW DELHI, Aug 16- India has capped prices of orthopaedic knee implants, in the country's latest move to bring down prices of medical devices. India's drug pricing authority said on Wednesday that orthopaedic implants in India had unjustified, unreasonable and irrationally high trade margins, leading to exorbitant pricing. Major international...

  • NEW DELHI, Aug 16- India has capped prices of orthopaedic knee implants, in the country's latest move to bring down prices of medical devices. India's drug pricing authority said on Wednesday that orthopaedic implants in India had unjustified, unreasonable and irrationally high trade margins, leading to exorbitant pricing. Major pharmaceutical companies...

  • NEW DELHI, Aug 16- India has capped prices of orthopaedic knee implants, in the country's latest move to bring down prices of medical devices. India's drug pricing authority said on Wednesday that orthopaedic implants in India had unjustified, unreasonable and irrationally high trade margins, leading to exorbitant pricing. Major pharmaceutical companies...

  • NEW DELHI, Aug 16- India has capped prices of orthopedic knee implants, in the country's latest move to bring down prices of medical devices. India's drug pricing authority said on Wednesday that orthopedic implants in India had unjustified, unreasonable and irrationally high trade margins, leading to exorbitant pricing. Major pharmaceutical companies have...

  • NEW DELHI, Aug 16- India has capped prices of orthopedic knee implants, in the country's latest move to bring down prices of medical devices. India's drug pricing authority said on Wednesday that orthopedic implants in India had unjustified, unreasonable and irrationally high trade margins, leading to exorbitant pricing. Major pharmaceutical companies have...

  • Cramer Remix: 3 red-hot stocks ready to roar higher

    Jim Cramer crowned three medical device players as winners with plenty more room to run.

  • Jim Cramer on Mad Money.

    Jim Cramer crowned three medical device players as winners with plenty more room to run.

  • Stryker CEO: For us it's always about innovation in medtech

    Kevin Lobo, Stryker CEO, talks the company's mission to provide high-tech, innovative devices for treating patients, including robotic assistance in the operating room.

  • REPUBLICAN SENATE HEALTHCARE BILL REPEALS MEDICAL DEVICES TAX THROUGH DEC. 31, 2020.

  • To bolster its position in the TAVR market in Europe, Boston Scientific in May bought Swiss medical device maker Symetis SA- the fourth-largest player in the multi-billion dollar market- for $435 million. The deal came after Boston Scientific's February recall of its Lotus heart valve devices from Europe and other regions following reports of a faulty...

  • Sales in Boston Scientific's cardiovascular unit- its biggest by revenue- rose 4.7 percent to $876 million in the second quarter ended June 30. Boston Scientific, which closed a $435 million acquisition of Swiss medical device maker Symetis SA in May, posted net profit of $146 million, or 11 cents per share, compared with a net loss of $207 million, or 15 cents per...

  • July 27- Medical device maker Boston Scientific Corp on Thursday posted a profit in the second quarter compared with a year-ago loss, helped by higher sales as well as lower litigation-related expenses. The company posted a net profit of $146 million, or 11 cents per share in the quarter ended June 30, compared with a net loss of $207 million, or 15 cents per share, a...

  • July 20- Abbott Laboratories on Thursday raised its full-year adjusted profit forecast as the diversified healthcare company gains from its $25 billion acquisition of medical devices maker St. The company raised its full-year adjusted earnings from continuing operations by 3 cents to a range of $2.43 per share to $2.53 per share. Abbott, which agreed to buy...

  • Cramer Remix: Snap is the No. 1 reason to own Facebook

    Jim Cramer broke down his strategy to why Snap fell out of his favor.